Russian MedicineRussian MedicineРоссийский медицинский журнал0869-21062412-9100Eco-Vector10629310.17816/0869-2106-2021-27-4-407-418ReviewsНаучные обзорыReview ArticleNeurological and psychological manifestations and consequences of an acute severe acute respiratory syndrome coronavirus 2 infectionНеврологические и психологические проявления и последствия после перенесенной острой инфекции SARS-CоV-2https://orcid.org/0000-0003-1519-23191234-3410GuryanovaEvgeniya A.ГурьяноваЕвгения Аркадьевна
Russian Federation

MD, Dr. Sci. (Med.), Professor

д.м.н., профессор

z-guryanova@bk.ruhttps://orcid.org/0000-0001-8107-36719811-9509DeomidovEvgeniy S.ДеомидовЕвгений Сергеевич
Russian Federation

MD, Cand. Sci. (Med.), Assistant Professor

к.м.н., доцент

neurokaf@yandex.ruhttps://orcid.org/0000-0001-7942-1710IlinaMaria K.ИльинаМария Константиновна
Russian Federation
mari.ilina99@mail.ruI.N. Ulyanov Chuvash State UniversityЧувашский государственный университет имени И.Н. УльяноваPostgraduate Doctors’ Training InstituteИнститут усовершенствования врачей150720212744074181504202215042022Copyright ©; 2021, Eco-VectorCopyright ©; 2021, ООО "Эко-Вектор"2021Eco-VectorООО "Эко-Вектор"https://medjrf.com/0869-2106/article/view/106293

Vital activity restoration in patients with fatigue syndrome after coronavirus disease-2019 and myalgic encephalomyelitis/chronic fatigue syndrome is a priority in the medical rehabilitation of this category of patients. This study aimed to review the literature using Russian and international sources and present data from contemporary studies on symptoms, possible pathophysiology and proposed treatment for neurological manifestations of consequences after an acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The recovery level of vital activity after acute infection with SARS-CoV-2 is low, and neurological symptoms persist in many patients. Chronic fatigue syndrome gradually develops in patients with a history of the disease, which subsequently leads to mental disorders, due to decreased physical activity.

Восстановление жизненной активности у пациентов с синдромом усталости после COVID-19 и миалгическим энцефаломиелитом / синдромом хронической усталости является приоритетной задачей медицинской реабилитации данной категории больных. Цель работы — обзор литературы, с использованием российских и зарубежных источников и представить данные современных исследований по симптомам, возможной патофизиологии и предлагаемого лечения неврологических проявлений последствий после перенесенной острой инфекции SARS-CoV-2. Уровень восстановления жизненной активности после перенесенной острой инфекции SARS-CoV-2 оказывается невысоким, у многих больных сохраняются неврологические симптомы. В результате снижения физической активности у переболевших постепенно развивается синдром хронической усталости, который в дальнейшем приводит к психическим расстройствам.

reviewCOVID-19coronavirussevere acute respiratory syndromeSARS-CoV-2pandemiccentral nervous systemperipheral nervous systemfatigue syndrome after COVID-19myalgic encephalomyelitischronic fatigue syndromeобзорCOVID-19коронавирустяжелый острый респираторный синдромSARS-CoV-2пандемияцентральная нервная системапериферическая нервная системасиндром усталости после COVID-19миалгический энцефаломиелитсиндром хронической усталостиLeung TYM, Chan AYL, Chan EW, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020;9(1):2190–2199. doi: 10.1080/22221751.2020.1825914Leung T.Y.M., Chan A.Y.L., Chan E.W., et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review // Emerg Microbes Infect. 2020. Vol. 9, N 1. P. 2190–2199. doi: 10.1080/22221751.2020.1825914Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615. doi: 10.1038/s41591-021-01283-zNalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome // Nat Med. 2021. Vol. 27, N 4. P. 601–615. doi: 10.1038/s41591-021-01283-zMansueto G. COVID-19: Brief check through the pathologist's eye (autopsy archive). Pathol Res Pract. 2020;216(11):153195. doi: 10.1016/j.prp.2020.153195Mansueto G. COVID-19: Brief check through the pathologist's eye (autopsy archive) // Pathol Res Pract. 2020. Vol. 216, N 11. P. 153195. doi: 10.1016/j.prp.2020.153195Divani AA, Andalib S, Di Napoli M, et al. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights. J Stroke Cerebrovasc Dis. 2020;29(8):104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941Divani A.A., Andalib S., Di Napoli M., et al. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights // J Stroke Cerebrovasc Dis. 2020. Vol. 29, N 8. P. 104941. doi: 10.1016/j.jstrokecerebrovasdis.2020.104941Andalib S, Biller J, Di Napoli M, et al. Peripheral Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9. doi: 10.1007/s11910-021-01102-5Andalib S., Biller J., Di Napoli M., et al. Peripheral Nervous System Manifestations Associated with COVID-19 // Curr Neurol Neurosci Rep. 2021. Vol. 21, N 3. P. 9. doi: 10.1007/s11910-021-01102-5Divani AA, Andalib S, Biller J, et al. Central Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2020;20(12):60. doi: 10.1007/s11910-020-01079-7Divani A.A., Andalib S., Biller J., et al. Central Nervous System Manifestations Associated with COVID-19 // Curr Neurol Neurosci Rep. 2020. Vol. 20, N 12. P. 60. doi: 10.1007/s11910-020-01079-7Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. Vol. 395, N 10223. P. 497–506. doi: 10.1016/S0140-6736(20)30183-5Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis. 2020;94:44–48. doi: 10.1016/j.ijid.2020.03.004Wu D., Wu T., Liu Q., Yang Z. The SARS-CoV-2 outbreak: What we know // Int J Infect Dis. 2020. Vol. 94, N. P. 44–48. doi: 10.1016/j.ijid.2020.03.004Mao L, Wang M, Chen S, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study. JAMA Neurol. 2020;77(6):683–690. doi: 10.1001/jamaneurol.2020.1127Mao L., Wang M., Chen S., et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study // JAMA Neurol. 2020. Vol. 77, N 6. P. 683–690. doi: 10.1001/jamaneurol.2020.1127Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020;382(23):2268–2270. doi: 10.1056/NEJMc2008597Helms J., Kremer S., Merdji H., et al. Neurologic Features in Severe SARS-CoV-2 Infection // N Engl J Med. 2020. Vol. 382, N 23. P. 2268–2270. doi: 10.1056/NEJMc2008597Eliezer M, Hautefort C, Hamel AL, et al. Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19. JAMA Otolaryngol Head Neck Surg. 2020;146(7):674–675. doi: 10.1001/jamaoto.2020.0832Eliezer M., Hautefort C., Hamel A.L., et al. Sudden and Complete Olfactory Loss of Function as a Possible Symptom of COVID-19 // JAMA Otolaryngol Head Neck Surg. 2020. Vol. 146, N 7. P. 674–675. doi: 10.1001/jamaoto.2020.0832Spinato G, Fabbris C, Polesel J, et al. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020;323(20):2089–2090. doi: 10.1001/jama.2020.6771Spinato G., Fabbris C., Polesel J., et al. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infec- tion // JAMA. 2020. Vol. 323, N 20. P. 2089–2090. doi: 10.1001/jama.2020.6771Suwanwongse K, Shabarek N. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease. Cureus. 2020;12(4):e7561. doi: 10.7759/cureus.7561Suwanwongse K., Shabarek N. Rhabdomyolysis as a Presentation of 2019 Novel Coronavirus Disease // Cureus. 2020. Vol. 12, N 4. P. e7561. doi: 10.7759/cureus.7561Zhao H, Shen D, Zhou H, et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383–384. doi: 10.1016/s1474-4422(20)30109-5Zhao H., Shen D., Zhou H., et al. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? // Lancet Neurol. 2020. Vol. 19, N 5. P. 383–384. doi: 10.1016/s1474-4422(20)30109-5Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barre Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574–2576. doi: 10.1056/NEJMc2009191Toscano G., Palmerini F., Ravaglia S., et al. Guillain-Barre Syndrome Associated with SARS-CoV-2 // N Engl J Med. 2020. Vol. 382, N 26. P. 2574–2576. doi: 10.1056/NEJMc2009191Li Y, Wang M, Zhou Y, et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study. Stroke Vasc Neurol. 2020;5(3):279–284. doi: 10.1136/svn-2020-000431.Li Y., Wang M., Zhou Y., et al. Acute Cerebrovascular Disease Following COVID-19: A Single Center, Retrospective, Observational Study // Stroke Vasc Neurol. 2020. Vol. 5, N 3. P. 279–284. doi: 10.1136/svn-2020-000431.Oxley TJ, Mocco J, Majidi S, et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N Engl J Med. 2020;382(20):e60. doi: 10.1056/NEJMc2009787Oxley T.J., Mocco J., Majidi S., et al. Large-Vessel Stroke as a Presenting Feature of COVID-19 in the Young // N Engl J Med. 2020. Vol. 382, N 20. P. e60. doi: 10.1056/NEJMc2009787Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020;35:100669. doi: 10.1016/j.nmni.2020.100669Sharifi-Razavi A., Karimi N., Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? // New Microbes New Infect. 2020. Vol. 35, N. P. 100669. doi: 10.1016/j.nmni.2020.100669Zhao K, Huang J, Dai D, et al. Acute myelitis after SARS-CoV-2 infection: A case report. Med Rxiv. 2020. doi: 10.1101/2020.03.16.20035105Zhao K., Huang J., Dai D., et al. Acute myelitis after SARS-CoV-2 infection: A case report // Med Rxiv. 2020. doi: 10.1101/2020.03.16.20035105china.org.cn [Internat]. Xinhua. Beijing Hospital Confirms Nervous System Infections by Novel Coronavirus [cited 02 October 2021]. Available from: http://www.china.org.cn/china/2020-03/05/content_75777888.htmchina.org.cn [Internat]. Xinhua. Beijing Hospital Confirms Nervous System Infections by Novel Coronavirus [доступ от: 02.10.2021]. Доступно по ссылке: http://www.china.org.cn/china/2020-03/05/content_75777888.htmKarimi N, Sharifi Razavi A, Rouhani N. Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report. Iranian Red Crescent Medical Journal. 2020;22(3). doi: 10.5812/ircmj.102828Karimi N., Sharifi Razavi A., Rouhani N. Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report // Iranian Red Crescent Medical Journal. 2020. Vol. 22, N 3. P. e102828. doi: 10.5812/ircmj.102828Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55–58. doi: 10.1016/j.ijid.2020.03.062Moriguchi T., Harii N., Goto J., et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 // Int J Infect Dis. 2020. Vol. 94, N. P. 55–58. doi: 10.1016/j.ijid.2020.03.062Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):E119–E120. doi: 10.1148/radiol.2020201187Poyiadji N., Shahin G., Noujaim D., et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features // Radiology. 2020. Vol. 296, N 2. P. E119–E120. doi: 10.1148/radiol.2020201187Zhang T, Rodricks M, Hirsh, E. COVID-19-associated acute disseminated encephalomyelitis: A case report. Med Rxiv. doi: 10.1101/2020.04.16.20068148Zhang T., Rodricks M.B., Hirsh E. COVID-19-associated acute disseminated encephalomyelitis: A case report // Med Rxiv. 2020. doi: 10.1101/2020.04.16.20068148Zhou L., Zhang M., Wang J., Gao J. Sars-Cov-2: Underestimated damage to nervous system // Travel Medicine and Infectious Disease. 2020. Vol. 36, N. P. 101642. doi: 10.1016/j.tmaid.2020.101642Zhou L., Zhang M., Wang J., Gao J. Sars-Cov-2: Underestimated damage to nervous system // Travel Medicine and Infectious Dis ease. 2020. Vol. 36, N. P. 101642. doi: 10.1016/j.tmaid.2020.101642Xiang P, Xu X, Gao L, et al. First case of 2019 novel coronavirus disease with encephalitis. China Xiv. 2020.Xiang P, Xu X, Gao L, et al. First case of 2019 novel coronavirus disease with encephalitis // China Xiv. 2020.Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi: 10.1016/S0140-6736(20)30628-0Mehta P., McAuley D.F., Brown M., et al. COVID-19: consider cytokine storm syndromes and immunosuppression // Lancet. 2020. Vol. 395, N 10229. P. 1033–1034. doi: 10.1016/S0140-6736(20)30628-0Wan Y, Shang J, Graham R, et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94(7). doi: 10.1128/JVI.00127-20Wan Y., Shang J., Graham R., et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus // J Virol. 2020. Vol. 94, N 7. P. e00127-20. doi: 10.1128/JVI.00127-20Kany S, Vollrath JT, Relja B. Cytokines in Inflammatory Disease. Int J Mol Sci. 2019;20(23). doi: 10.3390/ijms20236008Kany S., Vollrath J.T., Relja B. Cytokines in Inflammatory Disease // Int J Mol Sci. 2019. Vol. 20, N 23. P. 6008. doi: 10.3390/ijms20236008Wrapp D, Wang N, Corbett KS, et al. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. bioRxiv. 2020. doi: 10.1101/2020.02.11.944462Wrapp D., Wang N., Corbett K.S., et al. Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation // Science. 2020. Vol. 367, N 6483. P. 1260–1263. doi: 10.1126/science.abb2507Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–555. doi: 10.1002/jmv.25728Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients // J Med Virol. 2020. Vol. 92, N 6. P. 552–555. doi: 10.1002/jmv.25728Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995–998. doi: 10.1021/acschemneuro.0c00122Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms // ACS Chem Neurosci. 2020. Vol. 11, N 7. P. 995–998. doi: 10.1021/acschemneuro.0c00122Guo J, Huang Z, Lin L, Lv J. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. J Am Heart Assoc. 2020;9(7):e016219. doi: 10.1161/JAHA.120.016219Guo J., Huang Z., Lin L., Lv J. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection // J Am Heart Assoc. 2020. Vol. 9, N 7. P. e016219. doi: 10.1161/JAHA.120.016219Wang HY, Li XL, Yan ZR, et al. Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord. 2020;13:1756286420917830. doi: 10.1177/1756286420917830Wang H.Y., Li X.L., Yan Z.R., et al. Potential neurological symptoms of COVID-19 // Ther Adv Neurol Disord. 2020. Vol. 13, P. 1756286420917830. doi: 10.1177/1756286420917830Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7(1):11. doi: 10.1186/s40779-020-00240-0Guo Y.R., Cao Q.D., Hong Z.S., et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status // Mil Med Res. 2020. Vol. 7, N 1. P. 11. doi: 10.1186/s40779-020-00240-0Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-e605. doi: 10.1212/WNL.0000000000009619Gutierrez-Ortiz C., Mendez-Guerrero A., Rodrigo-Rey S., et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19 // Neurology. 2020. Vol. 95, N 5. P. e601–e605. doi: 10.1212/WNL.0000000000009619Goertz YMJ, Van Herck M, Delbressine JM, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post- COVID-19 syndrome? ERJ Open Res. 2020;6(4). doi: 10.1183/23120541.00542-2020Goertz Y.M.J., Van Herck M., Delbressine J.M., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? // ERJ Open Res. 2020. Vol. 6, N 4. P. 00542–2020. doi: 10.1183/23120541.00542-2020Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998. doi: 10.15585/mmwr.mm6930e1Tenforde M.W., Kim S.S., Lindsell C.J., et al. Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States, March-June 2020 // MMWR Morb Mortal Wkly Rep. 2020. Vol. 69, N 30. P. 993–998. doi: 10.15585/mmwr.mm6930e1Ministerstvo zdravookhraneniya RF. Vremennye metodicheskie rekomendatsii "Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19) Versiya 11" (utv. Ministerstvom zdravookhraneniya RF 7 maya 2021 g.). Ministerstvo zdravookhraneniya RF; 2021. (In Russ).Министерство здравоохранения РФ. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19) Версия 11» (утв. Министерством здравоохранения РФ 7 мая 2021 г.). Министерство здравоохранения РФ, 2021.Moghimi N, Di Napoli M, Biller J, et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep. 2021;21(9):44. doi: 10.1007/s11910-021-01130-1Moghimi N., Di Napoli M., Biller J., et al. The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection // Curr Neurol Neurosci Rep. 2021. Vol. 21, N 9. P. 44. doi: 10.1007/s11910-021-01130-1Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. doi: 10.1001/jama.2020.1260Carfi A., Bernabei R., Landi F., Gemelli Against C.-P.-A.C.S.G. Persistent Symptoms in Patients After Acute COVID-19 // JAMA. 2020. Vol. 324, N 6. P. 603–605. doi: 10.1001/jama.2020.12603Mandal S, Barnett J, Brill SE, et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396–398. doi: 10.1136/thoraxjnl-2020-215818Mandal S., Barnett J., Brill S.E., et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19 // Thorax. 2021. Vol. 76, N 4. P. 396–398. doi: 10.1136/thoraxjnl-2020-215818Davis HE, Assaf GS, McCorkell L, et al. Characterizing long covid in an international cohort: 7 months of symptoms and their impact. Med Rxiv. 2020. doi: 10.1101/2020.12.24.20248802.Davis H.E., Assaf G.S., McCorkell L., et al. Characterizing long covid in an international cohort: 7 months of symptoms and their impact // Med Rxiv. 2020. doi: 10.1101/2020.12.24.20248802.Townsend L, Dowds J, O'Brien K, et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc. 2021;18(6):997–1003. doi: 10.1513/AnnalsATS.202009-1175OCTownsend L., Dowds J., O'Brien K., et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity // Ann Am Thorac Soc. 2021. Vol. 18, N 6. P. 997–1003. doi: 10.1513/AnnalsATS.202009-1175OCHuang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. doi: 10.1016/s0140-6736(20)32656-8Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study // Lancet. 2021. Vol. 397, N 10270. P. 220–232. doi: 10.1016/s0140-6736(20)32656-8Chopra V, Flanders SA, O'Malley M, et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021;174(4):576–578. doi: 10.7326/M20-5661Chopra V., Flanders S.A., O'Malley M., et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19 // Ann Intern Med. 2021. Vol. 174, N 4. P. 576–578. doi: 10.7326/M20-5661Carvalho-Schneider C, Laurent E, Lemaignen A, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258–263. doi: 10.1016/j.cmi.2020.09.052Carvalho-Schneider C., Laurent E., Lemaignen A., et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset // Clin Microbiol Infect. 2021. Vol. 27, N 2. P. 258–263. doi: 10.1016/j.cmi.2020.09.052Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021;93(2):1013–1022. doi: 10.1002/jmv.26368Halpin S.J., McIvor C., Whyatt G., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation // J Med Virol. 2021. Vol. 93, N 2. P. 1013–1022. doi: 10.1002/jmv.26368Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4–e6. doi: 10.1016/j.jinf.2020.08.029Garrigues E., Janvier P., Kherabi Y., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19 // J Infect. 2020. Vol. 81, N 6. P. e4–e6. doi: 10.1016/j.jinf.2020.08.029Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? Med Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469Wostyn P. COVID-19 and chronic fatigue syndrome: Is the worst yet to come? // Med Hypotheses. 2021. Vol. 146, N. P. 110469. doi: 10.1016/j.mehy.2020.110469Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953–959. doi: 10.7326/0003-4819-121-12-199412150-00009Fukuda K., Straus S.E., Hickie I., et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group // Ann Intern Med. 1994. Vol. 121, N 12. P. 953–959. doi: 10.7326/0003-4819-121-12-199412150-00009Reeves WC, Lloyd A, Vernon SD, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003;3(1):25. doi: 10.1186/1472-6963-3-25Reeves W.C., Lloyd A., Vernon S.D., et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution // BMC Health Serv Res. 2003. Vol. 3, N 1. P. 25. doi: 10.1186/1472-6963-3-25Carruthers BM, van de Sande MI, De Meirleir KL, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327–338. doi: 10.1111/j.1365-2796.2011.02428.xCarruthers B.M., van de Sande M.I., De Meirleir K.L., et al. Myalgic encephalomyelitis: International Consensus Criteria // J Intern Med. 2011. Vol. 270, N 4. P. 327–338. doi: 10.1111/j.1365-2796.2011.02428.xMoss-Morris R, Deary V, Castell B. Chronic fatigue syndrome. Handb Clin Neurol. 2013;110:303–314. doi: 10.1016/B978-0-444-52901-5.00025-3Moss-Morris R., Deary V., Castell B. Chronic fatigue syndrome // Handb Clin Neurol. 2013. Vol. 110, N. P. 303–314. doi: 10.1016/B978-0-444-52901-5.00025-3Stefano GB. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID. Med Sci Monit. 2021;27:e931447. doi: 10.12659/MSM.931447Stefano G.B. Historical Insight into Infections and Disorders Associated with Neurological and Psychiatric Sequelae Similar to Long COVID // Med Sci Monit. 2021. Vol. 27, N. P. e931447. doi: 10.12659/MSM.931447Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study // BMC Neurol. 2011. Vol. 11, P. 37. doi: 10.1186/1471-2377-11-37Buszko M, Nita-Lazar A, Park JH, et al. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol. 2021;22(4):404–411. doi: 10.1038/s41590-021-00901-9Buszko M., Nita-Lazar A., Park J.H., et al. Lessons learned: new insights on the role of cytokines in COVID-19 // Nat Immunol. 2021. Vol. 22, N 4. P. 404–411. doi: 10.1038/s41590-021-00901-9van der Voort PHJ, Moser J, Zandstra DF, et al. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue. Heliyon. 2020;6(8):e04696. doi: 10.1016/j.heliyon.2020.e04696van der Voort P.H.J., Moser J., Zandstra D.F., et al. Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue // Heliyon. 2020. Vol. 6, N 8. P. e04696. doi: 10.1016/j.heliyon.2020.e04696Wang J, Xu Y, Zhang X, et al. Leptin correlates with monocytes activation and severe condition in COVID-19 patients. J Leukoc Biol. 2021;110(1):9–20. doi: 10.1002/JLB.5HI1020-704RWang J., Xu Y., Zhang X., et al. Leptin correlates with monocytes activation and severe condition in COVID-19 patients // J Leukoc Biol. 2021. Vol. 110, N 1. P. 9–20. doi: 10.1002/JLB.5HI1020-704RMinisterstvo zdravookhraneniya RF. Vremennye metodi cheskie rekomendatsii meditsinskaya reabilitatsiya pri novoi koronavirusnoi infektsii (COVID-19) versiya 2 (31.07.2020). Ministerstvo zdravookhraneniya RF; 2021.Министерство здравоохранения РФ. Временные методические рекомендации медицинская реабилитация при новой коронавирусной инфекции (COVID-19) версия 2 (31.07.2020). Министерство здравоохранения РФ, 2021.Guryanova EA, Tikhoplav OA, Tyurnikova SR. Klinicheskii sluchai reabilitatsii posle pnevmonii, assotsiirovannoi s COVID-19. Russian Journal of Rehabilitation Medicine. 2020;(4):22–35. (In Russ).Гурьянова Е.А., Тихоплав О.А., Тюрникова С.Р. Клинический случай реабилитации после пневмонии, ассоциированной с COVID-19 // Russian Journal of Rehabilitation Medicine. 2020. № 4. С. 22–35Tolle M, Freitag H, Antelmann M, et al. Myalgic Encephalomye litis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption. J Clin Med. 2020;9(8):2443. doi: 10.3390/jcm9082443Tolle M., Freitag H., Antelmann M., et al. Myalgic Encephalo myelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immuno adsorption // J Clin Med. 2020. Vol. 9, N 8. P. 2443. doi: 10.3390/jcm9082443